INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$1.1M

$1,125,193

Total Sells (Filtered)

$0

$0

View Combined Trades

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
NVCT P Nuvectis Pharma, Inc. BENTSUR RON • CEO Discretionary Buy 2025-11-05 $28,600 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	BENTSUR RON CEO Discretionary Buy	2025-11-05	$28,600	P	Form 4
NVCT P Nuvectis Pharma, Inc. Kaplan Matthew L. • Director Discretionary Buy 2025-11-05 $64,240 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	Kaplan Matthew L. Director Discretionary Buy	2025-11-05	$64,240	P	Form 4
NVCT P Nuvectis Pharma, Inc. Sanchez Juan • Director Discretionary BuyΔOwn +19.9% 2025-11-05 $75,270 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	Sanchez Juan Director Discretionary BuyΔOwn +19.9%	2025-11-05	$75,270	P	Form 4
NVCT P Nuvectis Pharma, Inc. Mosseri Marlio Charles • 10% Owner Discretionary Buy 2025-10-27 $457,410 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	Mosseri Marlio Charles 10% Owner Discretionary Buy	2025-10-27	$457,410	P	Form 4
NVCT P Nuvectis Pharma, Inc. Mosseri Marlio Charles • 10% Owner Discretionary Buy 2025-10-24 $215,459 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	Mosseri Marlio Charles 10% Owner Discretionary Buy	2025-10-24	$215,459	P	Form 4
NVCT P Nuvectis Pharma, Inc. Mosseri Marlio Charles • 10% Owner Discretionary Buy 2025-10-23 $284,214 View Form 4 →
NVCT	Nuvectis Pharma, Inc.	Mosseri Marlio Charles 10% Owner Discretionary Buy	2025-10-23	$284,214	P	Form 4